Benjamin J Maldonato

7PUBLICATIONS
87CO-AUTHORS
Molecular targetsPharmacogenomicsToxicology (incl. clinical toxicology)Pharmaceutical delivery technologiesSocial and cultural anthropology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 22, 2026
Selective Inhibition of KRASG13C Reveals an Increased Dependence on Wild-Type RAS Isoforms in Codon 13 RAS-Mutant Cancers.

|Feb 11, 2026
Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-Refractory KRASG12C-Mutant NSCLC for Immune Checkpoint Blockade.

Xing Wei, Cristina Blaj, M Ali Al-Radhawi

|Aug 18, 2024
Insights into pharmacogenetics, drug-gene interactions, and drug-drug-gene interactions.

Laura E Russell, Katrina G Claw, Kaja M Aagaard

|Jul 26, 2024
Enzyme-mediated drug-drug interactions: a review of in vivo and in vitro methodologies, regulatory guidance, and translation to the clinic.

Jaydeep Yadav, Benjamin J Maldonato, Joseph M Roesner

|Jul 05, 2024
Transporter-mediated drug-drug interactions: regulatory guidelines, in vitro and in vivo methodologies and translation, special populations, and the blood-brain barrier.

Laura E Russell, Jaydeep Yadav, Benjamin J Maldonato

|Apr 09, 2024
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers.

Jingjing Jiang, Lingyan Jiang, Benjamin J Maldonato

Pageof 2

Frequent Collaborators

3 joint publications

Ana G Vergara

3 joint publications

Zhican Wang

3 joint publications

Jacqueline A M Smith

3 joint publications

Laura E Russell